By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Media HydeMedia Hyde
  • Home
  • Politics
  • Education
  • Entertainment
  • Sports
  • Blogs
  • Business & Commerce
  • Others
    • Religious
    • Metropolitan
    • Climate and Weather
Font ResizerAa
Media HydeMedia Hyde
Font ResizerAa
  • Home
  • Politics
  • Education
  • Entertainment
  • Sports
  • Blogs
  • Business & Commerce
  • Others
    • Religious
    • Metropolitan
    • Climate and Weather
Follow US
© 2026 Media Hyde Network. All Rights Reserved.
Health

Newborn Sold over Unpaid Hospital Bill in Karachi’s Memon Goth

Last updated: November 3, 2025 9:33 pm
Irma Khan
Share
SHARE

KARACHI: In a disturbing incident that raises grave concerns about medical-ethics and child-protection, a newborn was allegedly sold by a private hospital in the Memon Goth area of Karachi after the parents failed to pay the delivery expenses.

What happened

According to police officials, the hospital administration took the baby from the mother under the pretext of settling unpaid bills and later handed the newborn over to a third party, who then sold him. The complaint was filed by the father of the infant, leading to the registration of an FIR under human-trafficking and kidnapping laws.

Investigations revealed that one of the accused, Dr Zehra, allegedly told the mother she knew a woman who would cover the hospital costs in exchange for taking the child, while the other accused, Shama Baloch—an employee of the same facility—paid the outstanding amount and took custody of the newborn.

Immediate police action

Senior Superintendent of Police Malir, Abdul Khaliq Pirzada, confirmed that the hospital was sealed and the baby was recovered from Punjab and reunited with his parents. The two primary suspects remain at large and law-enforcement authorities are conducting raids to arrest them and investigate whether a broader network may be involved.

Why this matters

This case touches on multiple serious issues—ethical hospital conduct, the vulnerability of low-income families, the risk of human trafficking under the guise of “help”, and the gaps in regulation of private medical facilities. For the public, it underscores the importance of transparency in medical billing, informed consent, and protections for newborns and mothers in socio-economically disadvantaged settings.

The incident at the Memon Goth hospital is a stark reminder that safeguarding rights—especially of newborns and low-income families—requires vigilance, strong institutional governance and legal enforcement. As authorities continue their investigation, this case should prompt a wider public and policy-driven discussion about how such abuses can be prevented.

Share This Article
Email Copy Link Print
Previous Article Are Antibiotics, Several other Medications Quietly Damaging your Gut Microbiome?
Next Article Are Modern Lifestyles Silently Fueling a Global Migraine Epidemic?
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Sponsored Ads

Stay Connected

FacebookLike
XFollow
InstagramFollow
YoutubeSubscribe
WhatsAppFollow
ThreadsFollow
Karachi woman murdered in ‘honor’ attack, husband remains critical
Karachi woman murdered in ‘honor’ attack, husband remains critical
Court & Crime Headline
August 19, 2026
Khawaja Asif claims PTI leadership is actively seeking 'NRO' for Imran Khan
Khawaja Asif claims PTI leadership is actively seeking ‘NRO’ for Imran Khan
Headline Politics
August 19, 2026
Pakistan Slashes Petrol Prices by Rs8.50 per Litre
Pakistan Slashes Petrol Prices by Rs8.50 per Litre
Economy Headline
August 19, 2026
Iraqi detention centers hold dozens of trafficked Pakistani youths
Iraqi detention centers hold dozens of trafficked Pakistani youths
Breaking
August 19, 2026
El Niño’s Exit Offers Relief, But Drought Scars Persist
El Niño’s Exit Offers Relief, But Drought Scars Persist
Climate and Weather Headline
August 18, 2026
Tropical Storm Lala leaves Hawaii flooded and without power
Tropical Storm Lala leaves Hawaii flooded and without power
Climate and Weather Headline
August 18, 2026

You Might Also Like

Smoking Linked to Two Million Cardiovascular Deaths Worldwide Each Year: Experts
Health

Smoking Linked to Two Million Cardiovascular Deaths Worldwide Each Year: Experts

By
Misbah Jogyat
WASHINGTON: UnitedHealth has warned that the Trump administration’s planned Medicare obesity-drug pilot faces “notable challenges,” casting doubt over how smoothly the program can move ahead if major insurers stay cautious. Recent market reporting said the model depends heavily on participation from Medicare drug plans that cover most Part D enrollees, which makes the stance of large insurers especially important. The concern centers on a broader CMS effort to expand access to GLP-1 weight-loss medicines for seniors. Under CMS’s published framework, the longer-term BALANCE Model would begin in Medicare Part D in January 2027, while a temporary Medicare GLP-1 Bridge is designed to start earlier and give eligible beneficiaries short-term access before that main model begins. What makes this a little more complicated is that the short-term bridge and the longer pilot are not the same thing. CMS says the Medicare GLP-1 Bridge operates outside the normal Part D coverage and payment flow, meaning Part D sponsors are not directly involved in that bridge arrangement. In other words, insurer participation is a much bigger issue for the 2027 BALANCE rollout than for the bridge itself. That distinction matters because investors and drugmakers are watching this closely. Reports said shares of obesity-drug makers fell after UnitedHealth’s comments, largely because Medicare coverage is seen as a huge growth opportunity for drugs such as Wegovy and Zepbound. If major insurers hesitate, the program could struggle to achieve the scale CMS appears to want. There is already some evidence of resistance. MarketWatch reported that CVS Health has opted out, while UnitedHealth is still evaluating the structure and discussing possible changes with Medicare officials. That does not mean the program is dead, not yet anyway, but it does suggest the administration may need to revise the design or sweeten the terms if it wants broader insurer buy-in. The bigger backdrop here is cost. Medicare has long been wary of broad obesity-drug coverage because GLP-1 therapies are expensive and potentially involve very large patient populations. Earlier policy debates around these drugs were shaped by concerns that wide coverage could drive up federal spending sharply, even as supporters argued the medicines could reduce longer-term health costs tied to obesity. So the headline problem for CMS is pretty straightforward: it has created a short-term bridge that can move without direct Part D plan involvement, but the more ambitious long-term Medicare model still appears to need insurers on board. UnitedHealth’s warning does not shut the door, but it does signal that one of the industry’s biggest players thinks the current setup may not be ready for easy launch.
HeadlineHealth

UnitedHealth raises red flags over Medicare obesity-drug pilot

By
Mabruka Khan
Health

CEO Visits BMC Hospital to Speed Up Balochistan Health Card Program

By
Fatima Nadeem
Health

Rising Global Temperatures Linked to Increased Cancer Rates Among Women

By
Neha Ashraf
Media Hyde Media Hyde Dark
Facebook Twitter Youtube Rss Medium

About US

Media Hyde Network: Your instant connection to breaking stories and live updates. Stay informed with our real-time coverage across politics, tech, entertainment, and more. Your reliable source for 24/7 News.

Top Categories
  • Headline
  • Politics
  • Entertainment
  • Education
  • Sports
  • Religious
  • Metropolitan
  • Climate and Weather
Usefull Links
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Cookies Policy
  • Advertising Policy
  • Terms & Conditions

© 2025 Media Hyde Network. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?